Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemotherapy for metastatic bladder cancer.

Clinical oncology (Royal College of Radiologists (Great Britain)) - 1 Oct 2005

Roberts J T

Abstract excerpt

This paper reviews the current status of systemic chemotherapy in the management of advanced and metastatic urothelial cancer. The activity of a number of single agents and combination drug regimens is discussed, and the small number of randomised-controlled studies available is also considered. Prognostic factors for response and survival, particularly long-term survival after systemic chemotherapy, are also...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Cisplatin
Share to Doxorubicin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kidney Diseases

Share to Methotrexate

Share to Randomized Controlled Trials as Topic

Share to Survival

Share to Vinblastine

Source

Identifiers

PMID: 16238139
DOI: 10.1016/j.clon.2005.07.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chemotherapy for metastatic bladder cancer.PMID 16238139Read ↗

Systemic chemotherapy for patients with bladder cancer--current controversies and future directions.Semantic proximity Read ↗

Management of advanced bladder cancer in the era of targeted therapies.Semantic proximity Read ↗

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.Semantic proximity Read ↗

Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.Semantic proximity Read ↗

[Targeted therapy for locally advanced and/or metastatic bladder cancer].Semantic proximity Read ↗

Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?Semantic proximity Read ↗

Recommendations for the optimal management of early and advanced urothelial carcinoma.Semantic proximity Read ↗

Genetic determinants for chemo- and radiotherapy resistance in bladder cancerSemantic proximity Read ↗

The role of genomics in the management of advanced bladder cancer.Semantic proximity Read ↗

Bladder cancer: Chemotherapy and checkpoint blockade.Semantic proximity Read ↗

Novel agents in invasive urothelial cancer.Semantic proximity Read ↗

New Approaches to Targeting Epigenetic Regulation in Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.